A. Kantar (Bergamo (BG), Italy), M. Everard (Perth (WA), Australia), E. van Meel (Rotterdam, Netherlands), G. Cangiano (Verona (VR), Italy)
Late Breaking Abstract - Presence of coinfection is associated with a longer hospital stay in children with laboratory-confirmed pertussis w. yuqing (Suzhou, China)
|  |
Investigating the mechanisms of Bordetella pertussis-induced airway inflammation. I. Schiavoni (Rome, Italy), P. Leone (Rome, Italy), G. Fedele (Rome, Italy)
|  |
Molecular characterisation and clinical presentation of Mycoplasma pneumoniae lower respiratory tract infections in children J. Rodman Berlot (Ljubljana, Slovenia), D. Keše (Ljubljana, Slovenia), M. Praprotnik (Ljubljana, Slovenia), T. Mrvic (Ljubljana, Slovenia), R. Kogoj (Ljubljana, Slovenia), U. Krivec (Ljubljana, Slovenia)
|   |
The influence of modern microbiological methods on the antibiotic treatment of pneumonia in children V. Berce (Maribor, Slovenia), M. Tomazin (Maribor, Slovenia), B. Koren (Maribor, Slovenia), B. Lovrencic (Maribor, Slovenia)
|   |
Intrapleural use of dornase alfa and tissue plasminogen activator are successful as treatment in pediatric empyema: a pilot study M. Slaats (Antwerp, Belgium), J. De Dooy (Antwerp, Belgium), P. Lauwers (Antwerp, Belgium), P. Van Schil (Antwerp, Belgium), S. Verhulst (Antwerp, Belgium), J. Hendriks (Antwerp, Belgium)
|   |
Inhibitory effect of naringenin in airway mucus hypersecretion and the possible mechanism X. Hu (Wenzhu, China), H. Zhang (Wenzhu, China), S. Meng (Wenzhu, China), F. Lv (Wenzhu, China), L. Lin (Wenzhu, China)
|   |
Cytokines profile in RSV infection according to nutritional status. L. Fuenzalida (Santiago, Chile), G. Arias (Santiago, Chile), J. Inostroza (Temuco, Chile), D. García-Díaz (Santiago, Chile), G. Valderrama (Santiago, Chile)
|  |
The role of innate lymphoid cells in early life lung infection D. Swieboda (London, United Kingdom), R. Thwaites (London, United Kingdom), S. Nadel (London, United Kingdom), T. Hansel (London, United Kingdom), P. Openshaw (London, United Kingdom), F. Culley (London, United Kingdom)
|  |
Chitinase 3-like 1 protein plays a critical role in RSV-induced airway inflammation M. Kim (Seoul, Republic of Korea), D. Shim (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), M. Sohn (Seoul, Republic of Korea)
|  |
Differences between innate response in children with bronchiolitis versus recurrent wheezing. M. Garcia Garcia (Leganes, Spain), C. Calvo-Rey (Madrid, Spain), S. Quevedo-Teruel (Leganes, Spain), B. Sastre-Turrion (Madrid, Spain), S. Bellon-Alonso (Leganes, Spain), P. Alonso-Lopez (Leganes, Spain), A. Marques-Cabrero (Leganes, Spain), L. Remedios-Mateo (Leganes, Spain), A. Tellez-Manso (Leganes, Spain), V. Del Pozo-Abejon (Madrid, Spain)
|   |
Bronchiolitis under 6 months of age: time for changing definition? L. Petrarca (Rome, Italy), R. Nenna (Rome, Italy), A. Frassanito (Rome, Italy), A. Pierangeli (Rome, Italy), G. Di Mattia (Rome, Italy), C. Scagnolari (Rome, Italy), C. Urbano (Rome, Italy), M. Di Martino (Rome, Italy), D. La Regina (Rome, Italy), V. Ferraro (Rome, Italy), F. Midulla (Rome, Italy)
|  |
A phase-III multicenter, randomized, double-blind, controlled trial of high-dose inhaled nitric oxide in infants with acute bronchiolitis. A. Goldbart (Beer Sheva, Israel), I. Golan-Tripto (Beer Sheva, Israel), G. Pillar (Haifa, Israel), G. Levnat-Levanon (Haifa, Israel), O. Efrati (Ramat Gan, Israel), R. Spiegel (Afula, Israel), R. Lubetzky (Tel Aviv, Israel), M. Lavie (Tel Aviv, Israel), L. Carmon (Beer Sheva, Israel), M. Mizrahi (Nes Ziona, Israel), A. Nachum (Beer Sheva, Israel)
|   |
Inhaled fraction and granulometry of hypertonic saline solution Aerosol for the ambulatory management of newborn babies with viral bronchiolitis: size matters. M. BREMOND (TOURS, France)
|   |
Respiratory readmission rates differ in the year following hospitalisation with RSV and non-RSV bronchiolitis G. Saint (Liverpool, United Kingdom), B. Flanagan (Liverpool, United Kingdom), P. Mcnamara (Liverpool, United Kingdom)
|   |
Rhinovirus- induced wheezing in children with family history of asthma S. Mileva (Sofia, Bulgaria), S. Lazova (Sofia, Bulgaria), M. Yakova (Sofia, Bulgaria), S. Michailova (Sofia, Bulgaria)
|  |
Bronchiolitis: 5 years of follow-up A. Frassanito (Rome, Italy), R. Nenna (Rome, Italy), L. Petrarca (Rome, Italy), G. Di Mattia (Rome, Italy), A. Pierangeli (Rome, Italy), C. Scagnolari (Rome, Italy), F. Ravà (Rome, Italy), S. Fioroni (Rome, Italy), E. Marchionne (Rome, Italy), B. Foti (Rome, Italy), G. Lais (Rome, Italy), F. Midulla (Rome, Italy)
|   |
Respiratory Illness and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH In Infants with a Tracheostomy (Tr) in the CARESS Registry (2005-2016) I. Mitchell (Calgary, Canada), M. Saleem (Tor, Canada), K. Kim (Tor, Canada), P. Bosco (Hamilton, Canada), K. Lanctot (Toronto, Canada)
|  |
The effect of ambient air pollution on the risk of hospitalisation with bronchiolitis in infants: A systematic review. C. King (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom), J. Kirkham (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom)
|  |
Calprotectin as new sensitive marker of neutrophilic inflammation in patients with bronchiolitis obliterans P. Jerkic (Frankfurt , Germany), F. Michel (Frankfurt , Germany), A. Kochems (Frankfurt , Germany), R. Schubert (Frankfurt , Germany), M. Rosewich (Frankfurt, Germany), S. Zielen (Frankfurt , Germany)
|   |